Arvinas, Inc. (ARVN)
12.37
+0.07
(+0.57%)
USD |
NASDAQ |
Feb 24, 16:00
12.60
+0.23
(+1.86%)
Pre-Market: 08:08
Arvinas EPS Diluted (Quarterly) : -1.038 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | -0.2898 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -67.40M |
| Revenue (Quarterly) | 9.50M |
| Total Expenses (Quarterly) | 76.90M |
| Enterprise Value | 117.95M |
| Profit Margin (Quarterly) | -709.5% |
| Earnings Yield | -9.83% |
| Normalized Earnings Yield | -9.516 |